We welcome investors and partners to learn more about our technology and financial milestones for the development of this breakthrough technology in biomarker discovery. Our progress to date has been possible thanks to our investors and funding bodies:
Partners
EXIT071
Leiden based startup developing innovative technology for the analysis of exosomes in therapeutics and diagnostics